Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
477.37
+5.37 (+1.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
July 02, 2024
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three.
Via
InvestorPlace
Vertex to Announce Second Quarter 2024 Financial Results on August 1
July 01, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
July 01, 2024
Via
Benzinga
3 Breakout Biotech Stocks on Track to Double by 2032
July 01, 2024
The tech sector has been at the forefront of the market rally in 2024. Consider these breakout biotech stocks as a great way to diversify.
Via
InvestorPlace
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
July 01, 2024
The latest bull market has plenty of intriguing buying opportunities.
Via
The Motley Fool
Peering Into Vertex Pharmaceuticals's Recent Short Interest
June 26, 2024
Via
Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX.
June 20, 2024
NASDAQ:VRTX is not too expensive for the growth it is showing.
Via
Chartmill
13 Analysts Have This To Say About Vertex Pharmaceuticals
June 17, 2024
Via
Benzinga
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now
June 28, 2024
Growth stocks with wide moats and strong financials can compound investor returns with time.
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
June 28, 2024
These healthcare stocks have clear paths to growth over the next few years.
Via
The Motley Fool
2 Healthcare Stocks That Are Screaming Buys in June
June 28, 2024
These top healthcare stocks are no-brainer buys in 2024 and beyond.
Via
The Motley Fool
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
June 27, 2024
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.
Via
InvestorPlace
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
June 27, 2024
Via
Benzinga
Should Quality-Oriented Investors Explore VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)?
June 12, 2024
Why NASDAQ:VRTX Stands Out as a Quality Stock.
Via
Chartmill
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
June 27, 2024
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.
Via
The Motley Fool
3 Biotech Stocks That Could Make Your Grandchildren Rich
June 27, 2024
These biotech stocks are poised to generate significant returns to investors due to their high growth potential.
Via
InvestorPlace
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?
June 25, 2024
It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes.
Via
The Motley Fool
Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions
June 21, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
June 21, 2024
Lilly is a good pick...but this one is better.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
June 18, 2024
Via
Benzinga
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation
June 18, 2024
Evergreen business models make it easier to hold for the long run.
Via
The Motley Fool
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades'
June 17, 2024
On CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals, Kevin Simpson named ConocoPhillips, and Rob Sechan suggested AbbVie, with all four stocks having...
Via
Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
June 15, 2024
Want peace of mind about your investments? Consider these great stocks.
Via
The Motley Fool
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress
June 14, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
2 Healthcare Stocks to Buy Hand Over Fist in June
June 12, 2024
They both have pretty impressive pasts, and their prospects look just as bright.
Via
The Motley Fool
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday
June 11, 2024
Via
Benzinga
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
June 10, 2024
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.
Via
Talk Markets
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
June 09, 2024
These companies could generate explosive growth over time.
Via
The Motley Fool
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
June 07, 2024
Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .
Via
Benzinga
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®
June 07, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.